Today: 23 May 2026
Intel stock jumps 6.7% to start 2026 as chip rally returns — what investors watch next

Intel stock jumps 6.7% to start 2026 as chip rally returns — what investors watch next

NEW YORK, January 4, 2026, 04:51 ET — Market closed

  • Intel shares logged a sharp gain in Friday’s first U.S. session of 2026 as chipmakers led a broader rebound.
  • Investors’ near-term focus is on U.S. jobs and inflation data that can reset interest-rate expectations for tech stocks.
  • Intel’s CES presence next week and a late-January earnings window are the next key milestones.

Intel Corporation (INTC) shares rose $2.48, or 6.7%, to $39.38 on Friday, after trading between $37.41 and $39.86, as semiconductors powered Wall Street’s first session of 2026. Nvidia added 1.2% and Advanced Micro Devices gained 4.3%.

The Philadelphia Semiconductor Index, a benchmark of major chip stocks, climbed 4% as the Dow rose 0.66% and the S&P 500 gained 0.19%, while the Nasdaq finished slightly lower, Reuters reported. The split underscored how chipmakers were doing the heavy lifting for risk appetite heading into the new year.

Investors now face a busy January slate, led by the U.S. monthly employment report due Jan. 9 and consumer price index data on Jan. 13, both key to bets on Federal Reserve rate cuts. “The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, said. Lower rate expectations tend to support growth stocks by making future profits more valuable today. Reuters

For Intel, the sharp move comes as it tries to convince investors it can regain ground in PCs and servers while building a contract manufacturing business. That effort has left the stock sensitive to chip-demand headlines and to shifts in interest-rate expectations.

In the PC market, Intel has pegged the availability of its “Panther Lake” laptop chips for early 2026. Reuters previously reported the chips are designed to cut power use versus the prior generation, a key factor for thin-and-light laptops. Reuters

On the manufacturing side, Intel Foundry is trying to win customers that need chips made in outside factories — a segment dominated by Taiwan Semiconductor Manufacturing. Intel has warned that securing an external customer for its next-generation process technology is pivotal for the foundry push.

In a Dec. 29 filing, Intel said it completed the issuance and sale of 214,776,632 shares to Nvidia for $5.0 billion, at $23.28 per share, in a private placement. The shares were issued under a purchase agreement signed in September, the filing showed.

Traders are also looking ahead to Intel’s next earnings update for clues on margins and capital spending, two swing factors for the turnaround story. A Yahoo Finance earnings calendar lists Jan. 29 as the next expected report date.

In October, Intel forecast fourth-quarter revenue of $12.8 billion to $13.8 billion and guided to non-GAAP earnings per share of about 8 cents — a profit metric that excludes certain costs. Investors will watch whether Intel meets that range and how it frames demand for PCs and data-center chips.

Before the next session, investors will watch for product news from the Consumer Electronics Show in Las Vegas, where Intel says it will take part from Jan. 5-9. PC chipmakers often use the event to set expectations for the year’s notebook lineup.

With Intel closing just under $40, that round-number level is on technical analysts’ screens as a near-term resistance point. A move back toward Friday’s mid-$37 low would be an early test of how much of the rally was position-resetting versus fresh buying.

Stock Market Today

  • Q1 Aerospace Earnings: Ducommun and Rocket Lab Lead Strong Performances
    May 23, 2026, 5:17 PM EDT. Aerospace stocks posted robust Q1 results with revenues matching analysts' estimates and next-quarter guidance 1.4% ahead. Ducommun (NYSE:DCO) beat expectations with $209 million revenue, up 8.6%, driven by gains in commercial aerospace and defense sectors. CEO Stephen Oswald highlighted progress toward 2027 goals. Shares rose 1.6% post-report, trading at $142.92. Rocket Lab (NASDAQ:RKLB) excelled with 63.5% revenue growth to $200.3 million, surpassing forecasts, and shares surged 60.8% to $126.35. Its focus on small satellite launches positions it well in the expanding space market. As earnings season closes, these results underscore resilience amid market fluctuations and reveal key players advancing through innovation and strategic execution.

Latest articles

McDonald’s Shares Gain This Week With Margin Uncertainty in Focus

McDonald’s Shares Gain This Week With Margin Uncertainty in Focus

23 May 2026
McDonald’s shares closed Friday at $282.27, down 0.67% for the day but up 2.1% for the week. The company declared a quarterly dividend of $1.86 a share, payable June 16. Investors remain concerned about U.S. store margins despite a rebound in global and U.S. comparable sales. The New York Stock Exchange will be closed for Memorial Day on Monday.
Devon Energy’s $2.6 billion shale deal puts stock to the test before Tuesday

Devon Energy’s $2.6 billion shale deal puts stock to the test before Tuesday

23 May 2026
Devon Energy closed at $47.22 Friday, up 0.23% on the day but down 4.6% for the week after announcing a $2.6 billion purchase of Delaware Basin drilling rights. The deal adds 16,300 net undeveloped acres in New Mexico. Analysts questioned the price, with Devon shares falling 2.5% on the news. U.S. markets will reopen Tuesday after the Memorial Day break.
NextEra Energy Shares Dip Before Holiday; Tuesday Brings Next Test

NextEra Energy Shares Dip Before Holiday; Tuesday Brings Next Test

23 May 2026
NextEra Energy shares closed at $88.55 Friday, down 1.27% and 5.2% lower than last week, after announcing a $66.8 billion all-stock takeover of Dominion Energy. U.S. markets are closed until Tuesday for Memorial Day. The deal would give Dominion holders 25.5% of the combined company, creating the world’s largest regulated electric utility by market value.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Scientists Scanned Interstellar Comet 3I/ATLAS for Alien Signals — and Found Nothing
Next Story

Scientists Scanned Interstellar Comet 3I/ATLAS for Alien Signals — and Found Nothing

Go toTop